Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Retigabine 100mg tablets
0408010AJAAAAAA
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 200mg tablets
0408010AJAAABAB
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 300mg tablets
0408010AJAAACAC
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 400mg tablets
0408010AJAAADAD
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 50mg tablets
0408010AJAAAEAE
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Retigabine 50mg tablets and Retigabine 100mg tablets
0408010AJAAAFAF
|
Retigabine | Retigabine | Central Nervous System | No data available |
|
Trobalt 100mg tablets
0408010AJBBAAAA
|
Trobalt | Retigabine | Central Nervous System | No data available |
|
Trobalt 200mg tablets
0408010AJBBABAB
|
Trobalt | Retigabine | Central Nervous System | No data available |
|
Trobalt 300mg tablets
0408010AJBBACAC
|
Trobalt | Retigabine | Central Nervous System | No data available |
|
Trobalt 400mg tablets
0408010AJBBADAD
|
Trobalt | Retigabine | Central Nervous System | No data available |
|
Trobalt 50mg tablets
0408010AJBBAEAE
|
Trobalt | Retigabine | Central Nervous System | No data available |
|
Trobalt tablets starter pack
0408010AJBBAFAF
|
Trobalt | Retigabine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.